EC Healthcare (HKG:2138) expects its net loss to widen to between HK$380 million and HK$420 million for the fiscal year ended March 31, compared with a loss of HK$167.2 million a year earlier.
The company attributed the forecast mainly to non-cash impairment charges on goodwill, intangible assets, receivables and other assets, along with fair value losses on certain investments, according to a Hong Kong bourse filing on Thursday. Revenue is also expected to fall to HK$3.70 billion from HK$4.14 billion in the prior year.